Clinical-stage biotech advances late-stage neurology and metabolic assets with H2 2026 data catalysts on track.
MediciNova CEO Provides Shareholder Update
Healthcare
Page 2- Jun 30, 2026 · 08:00 · AIDR · Routine +01
Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members
Rocket Doctor Enters into a Primary Care Value-Based Care Agreement in the United States, Expanding In-Network Coverage by More Than 5 Million Members
- Jun 30, 2026 · 07:31 · BPC · Admin02
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine
- Jun 30, 2026 · 04:27 · 4565 · Routine +03
AI-driven GPCR drug discovery platform monetizing partnerships while transitioning to a profitable specialty pharma model in APAC.
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
- Jun 30, 2026 · 03:06 · VIVI · Routine +04
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
- Jun 29, 2026 · 20:00 · MIR · Routine +05
MedMira Reports Third Quarter Results FY2026
MedMira Reports Third Quarter Results FY2026
- Jun 29, 2026 · 20:00 · GSD · Routine −06
Devonian's cash runway narrows to months as Altius revenue vanishes and pipeline remains pre-revenue
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
- Jun 29, 2026 · 10:20 · NVRS · Admin07
Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice
Noveris Health Sciences Announces Upcoming AGM and Record Date, and receipt of CSE Notice
- Jun 29, 2026 · 10:00 · GDAI · Admin08
Cboe Canada Welcomes Listing of GuideAI Health Corp.
Cboe Canada Welcomes Listing of GuideAI Health Corp.
- Jun 29, 2026 · 08:30 · 4151 · Routine +09
Rare disease and oncology franchise delivering consistent, incremental clinical and regulatory milestones across multiple asset portfolios.
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sezary Syndrome
- Jun 29, 2026 · 08:00 · GDAI · Neutral10
AI-driven vascular disease detection moves to public markets, but execution and commercialization remain unproven.
GuideAI Health Corp. to Begin Trading on Cboe Canada Under the Symbol "GDAI"
- Jun 29, 2026 · 07:40 · HELP · Routine +11
Helus Pharma burns cash faster in Phase 3 ramp but secures $50M runway as HLP003 nears topline readout
Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results
- Jun 29, 2026 · 07:16 · PCRX · Routine +12
PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy
PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy
- Jun 29, 2026 · 07:00 · CNVI · Routine +13
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
- Jun 29, 2026 · 07:00 · DHT · Routine +14
FDA approval on schedule validates $300M Viridian thesis; milestone payment is expected cash outflow for long-dated royalty stream.
DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa(TM) (veligrotug-vvze)